These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 27347292

  • 21. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM, Francois J, Sreenivasan N, Wannemuehler K, Faye PC, Tohme RA, Delly P, Deslouches YG, Etheart MD, Dismer AM, Patel R, Date K.
    Vaccine; 2019 Oct 08; 37(43):6348-6355. PubMed ID: 31521413
    [Abstract] [Full Text] [Related]

  • 22. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A, Sarkar K, Haldar P, Ghosh R.
    Vaccine; 2020 Feb 29; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
    Aibana O, Franke MF, Teng JE, Hilaire J, Raymond M, Ivers LC.
    PLoS Negl Trop Dis; 2013 Nov 29; 7(11):e2576. PubMed ID: 24278498
    [Abstract] [Full Text] [Related]

  • 25. Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014.
    Scobie HM, Phares CR, Wannemuehler KA, Nyangoma E, Taylor EM, Fulton A, Wongjindanon N, Aung NR, Travers P, Date K.
    PLoS Negl Trop Dis; 2016 Dec 29; 10(12):e0005210. PubMed ID: 27992609
    [Abstract] [Full Text] [Related]

  • 26. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    Ferreras E, Matapo B, Chizema-Kawesha E, Chewe O, Mzyece H, Blake A, Moonde L, Zulu G, Poncin M, Sinyange N, Kasese-Chanda N, Phiri C, Malama K, Mukonka V, Cohuet S, Uzzeni F, Ciglenecki I, Danovaro-Holliday MC, Luquero FJ, Pezzoli L.
    PLoS One; 2019 Dec 29; 14(8):e0219040. PubMed ID: 31469853
    [Abstract] [Full Text] [Related]

  • 27. Rapid cholera outbreak control following catastrophic landslides and floods: A case study of Bududa district, Uganda.
    Bwire G, Tumuhairwe I, Kwagonza L, Wetaka MM, Nakinsige A, Arinitwe ES, Kemirembe J, Muruta A, Mugero C, Nalwadda CK, Okware SI.
    Afr Health Sci; 2023 Dec 29; 23(4):203-215. PubMed ID: 38974278
    [Abstract] [Full Text] [Related]

  • 28. Current and future cholera vaccines.
    Shaikh H, Lynch J, Kim J, Excler JL.
    Vaccine; 2020 Feb 29; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [Abstract] [Full Text] [Related]

  • 29. Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
    Edosa M, Jeon Y, Gedefaw A, Hailu D, Mesfin Getachew E, Mogeni OD, Jang GH, Mukasa D, Yeshitela B, Getahun T, Lynch J, Bouhenia M, Worku Demlie Y, Hussen M, Wossen M, Teferi M, Park SE.
    Clin Infect Dis; 2024 Jul 12; 79(Supplement_1):S20-S32. PubMed ID: 38996040
    [Abstract] [Full Text] [Related]

  • 30. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C, Weiss MG, Ali SM, Chaignat CL, Khatib AM, Reyburn R, Duintjer Tebbens RJ, Hutubessy R.
    PLoS Negl Trop Dis; 2012 Jul 12; 6(10):e1844. PubMed ID: 23056660
    [Abstract] [Full Text] [Related]

  • 31. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B.
    Bull World Health Organ; 1999 Jul 12; 77(10):837-42. PubMed ID: 10593032
    [Abstract] [Full Text] [Related]

  • 32. Using Mobile Health (mHealth) and geospatial mapping technology in a mass campaign for reactive oral cholera vaccination in rural Haiti.
    Teng JE, Thomson DR, Lascher JS, Raymond M, Ivers LC.
    PLoS Negl Trop Dis; 2014 Jul 12; 8(7):e3050. PubMed ID: 25078790
    [Abstract] [Full Text] [Related]

  • 33. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
    Sundaram N, Schaetti C, Merten S, Schindler C, Ali SM, Nyambedha EO, Lapika B, Chaignat CL, Hutubessy R, Weiss MG.
    BMC Public Health; 2016 Jan 14; 16():36. PubMed ID: 26762151
    [Abstract] [Full Text] [Related]

  • 34. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar.
    Schaetti C, Chaignat CL, Hutubessy R, Khatib AM, Ali SM, Schindler C, Weiss MG.
    Hum Vaccin; 2011 Dec 14; 7(12):1299-308. PubMed ID: 22108036
    [Abstract] [Full Text] [Related]

  • 35. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey.
    Ateudjieu J, Yakum MN, Goura AP, Tembei Ayok M, Guenou E, Kangmo Sielinou CB, Kiadjieu FF, Tsafack M, Douanla Koutio IM, Tchio-Nighie KH, Tchokomeni H, Ntsekendio PN, Sack DA.
    BMC Public Health; 2022 Feb 05; 22(1):238. PubMed ID: 35123444
    [Abstract] [Full Text] [Related]

  • 36. Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.
    Mukonka VM, Sialubanje C, Matapo BB, Chewe O, Ngomah AM, Ngosa W, Hamoonga R, Sinyange N, Mzyece H, Mazyanga L, Bakyaita N, Kapata N.
    BMJ Open; 2023 Oct 05; 13(10):e070796. PubMed ID: 37798024
    [Abstract] [Full Text] [Related]

  • 37. Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi.
    Ilboudo PG, Le Gargasson JB.
    BMC Infect Dis; 2017 Dec 19; 17(1):779. PubMed ID: 29258447
    [Abstract] [Full Text] [Related]

  • 38. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan.
    Porta MI, Lenglet A, de Weerdt S, Crestani R, Sinke R, Frawley MJ, Van Herp M, Zachariah R.
    Trans R Soc Trop Med Hyg; 2014 Dec 19; 108(12):810-5. PubMed ID: 25311798
    [Abstract] [Full Text] [Related]

  • 39. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda.
    Bwire G, Roskosky M, Ballard A, Brooks WA, Okello A, Rafael F, Ampeire I, Orach CG, Sack DA.
    BMJ Open; 2020 Dec 10; 10(12):e038464. PubMed ID: 33303438
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.